NioCorp Developments Ltd
TSX:NB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NioCorp Developments Ltd
TSX:NB
|
US |
|
E
|
Everest Consolidator Acquisition Corp
NYSE:MNTN
|
US |
|
Bank Sinarmas Tbk PT
IDX:BSIM
|
ID |
|
Bonava AB (publ)
STO:BONAV B
|
SE |
|
Goodtech ASA
OSE:GOD
|
NO |
|
Ajanta Pharma Ltd
NSE:AJANTPHARM
|
IN |
|
Superloop Ltd
ASX:SLC
|
AU |
|
MacroGenics Inc
NASDAQ:MGNX
|
US |
|
GeoVax Labs Inc
NASDAQ:GOVX
|
US |
|
W
|
Winpac Inc
KOSDAQ:097800
|
KR |
|
Lvji Technology Holdings Inc
HKEX:1745
|
CN |
|
S
|
Steep Hill Inc
CNSX:STPH
|
CA |
|
Amoeba SA
PAR:ALMIB
|
FR |
|
Ambarella Inc
NASDAQ:AMBA
|
US |
Cash Flow Statement
Cash Flow Statement
NioCorp Developments Ltd
| Jun-2021 | Jun-2022 | Jun-2023 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
(4)
|
(10)
|
(40)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
|
| Other Non-Cash Items |
1
|
4
|
21
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
|
| Cash Interest Paid |
1
|
0
|
0
|
|
| Change in Working Capital |
(1)
|
0
|
2
|
|
| Cash from Operating Activities |
(5)
N/A
|
(6)
-30%
|
(17)
-181%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(6)
|
(0)
|
0
|
|
| Other Items |
0
|
0
|
0
|
|
| Cash from Investing Activities |
(6)
N/A
|
(0)
+100%
|
0
N/A
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
11
|
5
|
2
|
|
| Net Issuance of Debt |
8
|
(0)
|
12
|
|
| Other |
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
18
N/A
|
4
-76%
|
15
+240%
|
|
| Change in Cash | ||||
| Effect of Foreign Exchange Rates |
(0)
|
(0)
|
(0)
|
|
| Net Change in Cash |
7
N/A
|
(2)
N/A
|
(3)
-44%
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(11)
N/A
|
(6)
+44%
|
(17)
-180%
|
|